Your browser doesn't support javascript.
loading
Directional Migration in Esophageal Squamous Cell Carcinoma (ESCC) is Epigenetically Regulated by SET Nuclear Oncogene, a Member of the Inhibitor of Histone Acetyltransferase Complex.
Yuan, Xiang; Wang, Xinshuai; Gu, Bianli; Ma, Yingjian; Liu, Yiwen; Sun, Man; Kong, Jinyu; Sun, Wei; Wang, Huizhi; Zhou, Fuyou; Gao, Shegan.
Afiliação
  • Yuan X; Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China, 471003; Department of Medical Oncology, Cancer Hospital, The First Affiliated Hospital, College of
  • Wang X; Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China, 471003; Department of Medical Oncology, Cancer Hospital, The First Affiliated Hospital, College of
  • Gu B; Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China, 471003.
  • Ma Y; Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China, 471003.
  • Liu Y; Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China, 471003.
  • Sun M; Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China, 471003.
  • Kong J; Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China, 471003.
  • Sun W; Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China, 471003.
  • Wang H; Department of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Room 263D, 501 South Preston Street, Louisville, KY 40202, USA.
  • Zhou F; Department of Thoracic Surgery, Anyang Tumor Hospital, Anyang, China, 455000.
  • Gao S; Henan Key Laboratory of Cancer Epigenetics; Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China, 471003; Department of Medical Oncology, Cancer Hospital, The First Affiliated Hospital, College of
Neoplasia ; 19(11): 868-884, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28938158
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oncogenes / Fatores de Transcrição / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Movimento Celular / Epigênese Genética / Histona Acetiltransferases / Chaperonas de Histonas Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oncogenes / Fatores de Transcrição / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Movimento Celular / Epigênese Genética / Histona Acetiltransferases / Chaperonas de Histonas Idioma: En Ano de publicação: 2017 Tipo de documento: Article